The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Coronary Vessels

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Coronary Vessels


Psychiatry related information on Coronary Vessels


High impact information on Coronary Vessels


Chemical compound and disease context of Coronary Vessels


Biological context of Coronary Vessels


Anatomical context of Coronary Vessels


Associations of Coronary Vessels with chemical compounds


Gene context of Coronary Vessels


Analytical, diagnostic and therapeutic context of Coronary Vessels


  1. Hemodynamic effects of sildenafil in men with severe coronary artery disease. Herrmann, H.C., Chang, G., Klugherz, B.D., Mahoney, P.D. N. Engl. J. Med. (2000) [Pubmed]
  2. Left ventricular function and rapid release of creatine kinase MB in acute myocardial infarction. Evidence for spontaneous reperfusion. Ong, L., Reiser, P., Coromilas, J., Scherr, L., Morrison, J. N. Engl. J. Med. (1983) [Pubmed]
  3. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. McFadden, E.P., Clarke, J.G., Davies, G.J., Kaski, J.C., Haider, A.W., Maseri, A. N. Engl. J. Med. (1991) [Pubmed]
  4. Plasma homocysteine levels and mortality in patients with coronary artery disease. Nygård, O., Nordrehaug, J.E., Refsum, H., Ueland, P.M., Farstad, M., Vollset, S.E. N. Engl. J. Med. (1997) [Pubmed]
  5. Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. Cabanes, L.R., Weber, S.N., Matran, R., Regnard, J., Richard, M.O., Degeorges, M.E., Lockhart, A. N. Engl. J. Med. (1989) [Pubmed]
  6. Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis. Williams, J.K., Shively, C.A., Clarkson, T.B. Circulation (1994) [Pubmed]
  7. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Haskell, W.L., Alderman, E.L., Fair, J.M., Maron, D.J., Mackey, S.F., Superko, H.R., Williams, P.T., Johnstone, I.M., Champagne, M.A., Krauss, R.M. Circulation (1994) [Pubmed]
  8. Alcohol and the cardiovascular system research challenges and opportunities. Lucas, D.L., Brown, R.A., Wassef, M., Giles, T.D. J. Am. Coll. Cardiol. (2005) [Pubmed]
  9. Rationale for treatment. Gotto, A.M. Am. J. Med. (1991) [Pubmed]
  10. Long-term statin use and psychological well-being. Young-Xu, Y., Chan, K.A., Liao, J.K., Ravid, S., Blatt, C.M. J. Am. Coll. Cardiol. (2003) [Pubmed]
  11. Positional cloning of the combined hyperlipidemia gene Hyplip1. Bodnar, J.S., Chatterjee, A., Castellani, L.W., Ross, D.A., Ohmen, J., Cavalcoli, J., Wu, C., Dains, K.M., Catanese, J., Chu, M., Sheth, S.S., Charugundla, K., Demant, P., West, D.B., de Jong, P., Lusis, A.J. Nat. Genet. (2002) [Pubmed]
  12. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. Herrington, D.M., Reboussin, D.M., Brosnihan, K.B., Sharp, P.C., Shumaker, S.A., Snyder, T.E., Furberg, C.D., Kowalchuk, G.J., Stuckey, T.D., Rogers, W.J., Givens, D.H., Waters, D. N. Engl. J. Med. (2000) [Pubmed]
  13. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. Newby, L.K., Eisenstein, E.L., Califf, R.M., Thompson, T.D., Nelson, C.L., Peterson, E.D., Armstrong, P.W., Van de Werf, F., White, H.D., Topol, E.J., Mark, D.B. N. Engl. J. Med. (2000) [Pubmed]
  14. Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. Ordovas, J.M., Schaefer, E.J., Salem, D., Ward, R.H., Glueck, C.J., Vergani, C., Wilson, P.W., Karathanasis, S.K. N. Engl. J. Med. (1986) [Pubmed]
  15. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. Golino, P., Piscione, F., Willerson, J.T., Cappelli-Bigazzi, M., Focaccio, A., Villari, B., Indolfi, C., Russolillo, E., Condorelli, M., Chiariello, M. N. Engl. J. Med. (1991) [Pubmed]
  16. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. Zavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., Bonati, P.A., Bergonzani, M., Gnudi, L., Passeri, M. N. Engl. J. Med. (1989) [Pubmed]
  17. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. Kuivenhoven, J.A., Jukema, J.W., Zwinderman, A.H., de Knijff, P., McPherson, R., Bruschke, A.V., Lie, K.I., Kastelein, J.J. N. Engl. J. Med. (1998) [Pubmed]
  18. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. Ludmer, P.L., Selwyn, A.P., Shook, T.L., Wayne, R.R., Mudge, G.H., Alexander, R.W., Ganz, P. N. Engl. J. Med. (1986) [Pubmed]
  19. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. Pitt, B., Waters, D., Brown, W.V., van Boven, A.J., Schwartz, L., Title, L.M., Eisenberg, D., Shurzinske, L., McCormick, L.S. N. Engl. J. Med. (1999) [Pubmed]
  20. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Miki, T., Suzuki, M., Shibasaki, T., Uemura, H., Sato, T., Yamaguchi, K., Koseki, H., Iwanaga, T., Nakaya, H., Seino, S. Nat. Med. (2002) [Pubmed]
  21. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Fisslthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D.R., Fleming, I., Busse, R. Nature (1999) [Pubmed]
  22. Platelet aggregation. Adult-onset diabetes mellitus and coronary artery disease. Davis, J.W., Phillips, P.E., Yue, K.T., Lewis, H.D., Hartman, C.R. JAMA (1978) [Pubmed]
  23. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. Treasure, C.B., Klein, J.L., Weintraub, W.S., Talley, J.D., Stillabower, M.E., Kosinski, A.S., Zhang, J., Boccuzzi, S.J., Cedarholm, J.C., Alexander, R.W. N. Engl. J. Med. (1995) [Pubmed]
  24. Hyaluronidase-induced reductions in myocardial infarct size. Maclean, D., Fishbein, M.C., Maroko, P.R., Braunwald, E. Science (1976) [Pubmed]
  25. Platelet-induced neurogenic coronary contractions due to accumulation of the false neurotransmitter, 5-hydroxytryptamine. Cohen, R.A. J. Clin. Invest. (1985) [Pubmed]
  26. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. Nakashima, M., Mombouli, J.V., Taylor, A.A., Vanhoutte, P.M. J. Clin. Invest. (1993) [Pubmed]
  27. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Ozcürümez, M., Kaminski, W.E., Hahmann, H.W., Oette, K., Rothe, G., Aslanidis, C., Lackner, K.J., Schmitz, G. Nat. Genet. (1999) [Pubmed]
  28. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. Gill, J.B., Ruddy, T.D., Newell, J.B., Finkelstein, D.M., Strauss, H.W., Boucher, C.A. N. Engl. J. Med. (1987) [Pubmed]
  29. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. Anderson, T.J., Meredith, I.T., Yeung, A.C., Frei, B., Selwyn, A.P., Ganz, P. N. Engl. J. Med. (1995) [Pubmed]
  30. In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries. May, D.C., Popma, J.J., Black, W.H., Schaefer, S., Lee, H.R., Levine, B.D., Hillis, L.D. N. Engl. J. Med. (1987) [Pubmed]
  31. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. Chesebro, J.H., Clements, I.P., Fuster, V., Elveback, L.R., Smith, H.C., Bardsley, W.T., Frye, R.L., Holmes, D.R., Vlietstra, R.E., Pluth, J.R., Wallace, R.B., Puga, F.J., Orszulak, T.A., Piehler, J.M., Schaff, H.V., Danielson, G.K. N. Engl. J. Med. (1982) [Pubmed]
  32. Apolipoprotein B-100 Hopkins (arginine4019----tryptophan). A new apolipoprotein B-100 variant in a family with premature atherosclerosis and hyperapobetalipoproteinemia. Ladias, J.A., Kwiterovich, P.O., Smith, H.H., Miller, M., Bachorik, P.S., Forte, T., Lusis, A.J., Antonarakis, S.E. JAMA (1989) [Pubmed]
  33. Lack of MEF2A mutations in coronary artery disease. Weng, L., Kavaslar, N., Ustaszewska, A., Doelle, H., Schackwitz, W., Hébert, S., Cohen, J.C., McPherson, R., Pennacchio, L.A. J. Clin. Invest. (2005) [Pubmed]
  34. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. Clee, S.M., Kastelein, J.J., van Dam, M., Marcil, M., Roomp, K., Zwarts, K.Y., Collins, J.A., Roelants, R., Tamasawa, N., Stulc, T., Suda, T., Ceska, R., Boucher, B., Rondeau, C., DeSouich, C., Brooks-Wilson, A., Molhuizen, H.O., Frohlich, J., Genest, J., Hayden, M.R. J. Clin. Invest. (2000) [Pubmed]
  35. A unique genetic and biochemical presentation of fish-eye disease. Kuivenhoven, J.A., van Voorst tot Voorst, E.J., Wiebusch, H., Marcovina, S.M., Funke, H., Assmann, G., Pritchard, P.H., Kastelein, J.J. J. Clin. Invest. (1995) [Pubmed]
  36. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. Chutkow, W.A., Pu, J., Wheeler, M.T., Wada, T., Makielski, J.C., Burant, C.F., McNally, E.M. J. Clin. Invest. (2002) [Pubmed]
  37. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. Egashira, K., Inou, T., Hirooka, Y., Yamada, A., Urabe, Y., Takeshita, A. N. Engl. J. Med. (1993) [Pubmed]
  38. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. Callister, T.Q., Raggi, P., Cooil, B., Lippolis, N.J., Russo, D.J. N. Engl. J. Med. (1998) [Pubmed]
  39. Antioxidants and atherosclerotic heart disease. Diaz, M.N., Frei, B., Vita, J.A., Keaney, J.F. N. Engl. J. Med. (1997) [Pubmed]
  40. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. Mangano, D.T., Layug, E.L., Wallace, A., Tateo, I. N. Engl. J. Med. (1996) [Pubmed]
WikiGenes - Universities